SCLX
NASDAQ · Pharmaceuticals
Scilex Holding Co
$6.45
-0.02 (-0.31%)
Open$6.57
Previous Close$6.47
Day High$6.69
Day Low$6.35
52W High$34.27
52W Low$4.20
Volume—
Avg Volume89.5K
Market Cap58.93M
P/E Ratio—
EPS$-35.63
SectorPharmaceuticals
Analyst Ratings
Strong Sell
6 analysts
Price Target
+497.4% upside
Current
$6.45
$6.45
Target
$38.53
$38.53
$25.32
$38.53 avg
$55.24
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 25.05M | 27.03M | 16.86M |
| Net Income | -297,037,909 | -288,510,811 | 3.00M |
| Profit Margin | -1,185.8% | -1,126.5% | 17.8% |
| EBITDA | -288,973,263 | -296,270,882 | 6.50M |
| Free Cash Flow | — | — | 2.15M |
| Rev Growth | -7.3% | -7.3% | +5.1% |
| Debt/Equity | — | — | 0.30 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |